334 related articles for article (PubMed ID: 32522372)
1. Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.
Monte Serrano J; Cruañes Monferrer J; García-García M; García-Gil MF
Med Clin (Barc); 2020 Sep; 155(5):231. PubMed ID: 32522372
[No Abstract] [Full Text] [Related]
2. Erythema multiforme in the context of SARS-Coronavirus-2 infection.
Sánchez-Velázquez A; Falkenhain D; Rivera Díaz R
Med Clin (Barc); 2020 Aug; 155(3):141. PubMed ID: 32475615
[No Abstract] [Full Text] [Related]
3. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
Cairoli E; Espinosa G
Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
[No Abstract] [Full Text] [Related]
4. Chloroquine and hydroxychloroquine in covid-19.
Ferner RE; Aronson JK
BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
[No Abstract] [Full Text] [Related]
5. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
[No Abstract] [Full Text] [Related]
6. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
Juurlink DN
CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
[No Abstract] [Full Text] [Related]
7. Covid-19 treatment update: follow the scientific evidence.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):43-53. PubMed ID: 32338320
[No Abstract] [Full Text] [Related]
8. Auditory Cinchonism in COVID Era.
Saniasiaya J; Kulasegarah J
Ear Nose Throat J; 2020 Nov; 99(9):597-598. PubMed ID: 32744901
[No Abstract] [Full Text] [Related]
9. Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
Rani S; Grover S; Mehra A; Sahoo S
Indian J Pharmacol; 2020; 52(3):229-231. PubMed ID: 32874009
[No Abstract] [Full Text] [Related]
10. Of chloroquine and COVID-19.
Touret F; de Lamballerie X
Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
Shih RD; Johnson HM; Maki DG; Hennekens CH
Am J Med; 2020 Sep; 133(9):1007-1008. PubMed ID: 32502485
[No Abstract] [Full Text] [Related]
12. Facts, not Fear: Safety of Hydroxychloroquine.
Kuraitis D; Murina A
Am J Med Sci; 2020 Aug; 360(2):199-200. PubMed ID: 32560964
[No Abstract] [Full Text] [Related]
13. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
[No Abstract] [Full Text] [Related]
14. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
[No Abstract] [Full Text] [Related]
15. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.
Redondo-Sendino Á; González Sánchez IC; de Victoria Fernández B
Med Clin (Barc); 2020 Nov; 155(9):414-415. PubMed ID: 32873395
[No Abstract] [Full Text] [Related]
16. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
Tomcsányi J; Tomcsányi K
Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
[TBL] [Abstract][Full Text] [Related]
17. Race to find COVID-19 treatments accelerates.
Kupferschmidt K; Cohen J
Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
[No Abstract] [Full Text] [Related]
18. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.
Vitte J; Michel M; Mezouar S; Diallo AB; Boumaza A; Mege JL; Desnues B
Front Immunol; 2020; 11():2159. PubMed ID: 32983179
[TBL] [Abstract][Full Text] [Related]
19. Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.
Funnell SGP; Dowling WE; Muñoz-Fontela C; Gsell PS; Ingber DE; Hamilton GA; Delang L; Rocha-Pereira J; Kaptein S; Dallmeier KH; Neyts J; Rosenke K; de Wit E; Feldmann H; Maisonnasse P; Le Grand R; Frieman MB; Coleman CM
Nat Commun; 2020 Aug; 11(1):4253. PubMed ID: 32848158
[TBL] [Abstract][Full Text] [Related]
20. Repurposing antimalarials and other drugs for COVID-19.
Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
